合計 50 件の最近のインサイダー取引記録が記録されています Miromatrix Medical Inc. (MIRO), 内訳は 29 件の買い および 18 件の売り. インサイダー買い総額は $999.39K インサイダー売り総額は $2.08M.
最近活動のある主要インサイダーには Kattungal Laji, Erb John L, Buckman Paul. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — MIRO
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-07-16 |
Kattungal Laji |
Vice President of Quality |
処分 |
80,000 |
$3.75 |
$300K |
- |
| 2023-12-13 |
Erb John L |
Director |
株式返還 |
25,000 |
$3.75 |
$93.75K |
- |
| 2023-12-13 |
Buckman Paul |
Director |
株式返還 |
25,000 |
$3.75 |
$93.75K |
- |
| 2023-12-13 |
Maag Peter |
Director |
株式返還 |
58,368 |
- |
- |
- |
| 2023-12-13 |
Burke William P. Mr. |
Director |
株式返還 |
67,413 |
- |
- |
- |
| 2023-12-13 |
Heine Lisa Wipperman |
Director |
株式返還 |
67,413 |
- |
- |
- |
| 2023-12-13 |
Ross Jeffrey James |
Chief Executive Officer |
株式返還 |
100,000 |
$3.26 |
$326K |
- |
| 2023-12-13 |
Douglas James Michael |
Chief Financial Officer |
株式返還 |
40,000 |
$3.26 |
$130.4K |
- |
| 2023-12-12 |
Erb John L |
Director |
TOB(売り) |
56,260 |
$1.75 |
$98.46K |
54,201 |
| 2023-12-12 |
Buckman Paul |
Director |
TOB(売り) |
52,593 |
$1.75 |
$92.04K |
54,201 |
| 2023-12-12 |
Maag Peter |
Director |
TOB(売り) |
62,092 |
$1.75 |
$108.66K |
58,368 |
| 2023-12-12 |
Burke William P. Mr. |
Director |
TOB(売り) |
66,943 |
$1.75 |
$117.15K |
67,413 |
| 2023-12-12 |
Heine Lisa Wipperman |
Director |
TOB(売り) |
66,943 |
$1.75 |
$117.15K |
67,413 |
| 2023-12-12 |
Ross Jeffrey James |
Chief Executive Officer |
TOB(売り) |
308,775 |
$1.75 |
$540.36K |
87,500 |
| 2023-12-12 |
Douglas James Michael |
Chief Financial Officer |
TOB(売り) |
31,250 |
$1.75 |
$54.69K |
20,000 |
| 2023-12-12 |
United Therapeutics Corp |
10 Percent Owner |
処分 |
- |
- |
- |
27,419,228 |
| 2023-06-01 |
Erb John L |
Director |
RSU 付与(制限付株式) |
54,201 |
- |
- |
110,461 |
| 2023-06-01 |
Buckman Paul |
Director |
RSU 付与(制限付株式) |
54,201 |
- |
- |
106,794 |
| 2023-06-01 |
Maag Peter |
Director |
RSU 付与(制限付株式) |
54,201 |
- |
- |
120,460 |
| 2023-06-01 |
Burke William P. Mr. |
Director |
RSU 付与(制限付株式) |
54,201 |
- |
- |
134,356 |
| 2023-06-01 |
Heine Lisa Wipperman |
Director |
RSU 付与(制限付株式) |
54,201 |
- |
- |
134,356 |
| 2023-03-10 |
Erb John L |
Director |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
56,260 |
| 2023-03-10 |
Buckman Paul |
Director |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
52,593 |
| 2023-03-10 |
Maag Peter |
Director |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
66,259 |
| 2023-03-10 |
Burke William P. Mr. |
Director |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
80,155 |
| 2023-03-10 |
Heine Lisa Wipperman |
Director |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
80,155 |
| 2023-03-10 |
Ross Jeffrey James |
Chief Executive Officer |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
396,276 |
| 2023-03-10 |
Barry John Joseph |
Vice President of R&d |
情報に基づく買い |
6,250 |
$1.60 |
$10K |
35,485 |
| 2023-03-10 |
Douglas James Michael |
Chief Financial Officer |
情報に基づく買い |
31,250 |
$1.60 |
$50K |
51,250 |
| 2023-01-13 |
Ross Jeffrey James |
Chief Executive Officer |
RSU 付与(制限付株式) |
100,000 |
- |
- |
100,000 |
| 2023-01-13 |
Barry John Joseph |
Vice President of R&d |
RSU 付与(制限付株式) |
20,000 |
- |
- |
20,000 |
| 2023-01-13 |
Douglas James Michael |
Chief Financial Officer |
RSU 付与(制限付株式) |
20,000 |
- |
- |
20,000 |
| 2022-12-06 |
Ross Jeffrey James |
Chief Executive Officer |
オプション行使(売却) |
37,500 |
- |
- |
- |
| 2022-10-01 |
Barry John Joseph |
Vice President of R&d |
RSU 源泉徴収 |
765 |
$4.38 |
$3.35K |
19,235 |
| 2022-08-10 |
Erb John L |
Director |
RSU 付与(制限付株式) |
12,788 |
- |
- |
25,010 |
| 2022-08-10 |
Buckman Paul |
Director |
RSU 付与(制限付株式) |
12,788 |
- |
- |
21,343 |
| 2022-08-10 |
Maag Peter |
Director |
RSU 付与(制限付株式) |
12,788 |
- |
- |
35,009 |
| 2022-08-10 |
Burke William P. Mr. |
Director |
RSU 付与(制限付株式) |
12,788 |
- |
- |
48,905 |
| 2022-08-10 |
Heine Lisa Wipperman |
Director |
RSU 付与(制限付株式) |
12,788 |
- |
- |
48,905 |
| 2022-03-15 |
Ross Jeffrey James |
Chief Executive Officer |
オプション行使 |
35,438 |
$1.25 |
$44.3K |
293,588 |
| 2022-03-01 |
Douglas James Michael |
Officer |
不明 |
- |
- |
- |
- |
| 2022-03-01 |
Douglas James Michael |
Chief Financial Officer |
RSU 付与(制限付株式) |
180,000 |
- |
- |
180,000 |
| 2022-01-13 |
Niebur Brian |
Chief Financial Officer |
RSU 付与(制限付株式) |
20,000 |
$4.20 |
$84K |
20,000 |
| 2022-01-13 |
Kattungal Laji |
Vice President of Quality |
RSU 付与(制限付株式) |
10,000 |
- |
- |
10,000 |
| 2022-01-13 |
Ross Jeffrey James |
Chief Executive Officer |
RSU 付与(制限付株式) |
100,000 |
$4.20 |
$420K |
100,000 |
| 2022-01-13 |
Barry John Joseph |
Vice President of R&d |
RSU 付与(制限付株式) |
20,000 |
$4.20 |
$84K |
20,000 |
| 2022-01-03 |
Niebur Brian |
Chief Financial Officer |
RSU 付与(制限付株式) |
1,500 |
$4.73 |
$7.1K |
1,500 |
| 2022-01-03 |
Burke William P. Mr. |
Director |
不明 |
- |
- |
- |
- |
| 2022-01-03 |
Burke William P. Mr. |
Director |
RSU 付与(制限付株式) |
4,405 |
- |
- |
4,405 |
| 2022-01-03 |
Heine Lisa Wipperman |
Director |
不明 |
- |
- |
- |
- |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効